| Acute myeloid leukemia, version 3.2019, NCCN clinical practice guidelines in oncology MS Tallman, ES Wang, JK Altman, FR Appelbaum, VR Bhatt, D Bixby, ... Journal of the National Comprehensive Cancer Network 17 (6), 721-749, 2019 | 421 | 2019 |
| Acute myeloid leukemia, version 3.2017, NCCN clinical practice guidelines in oncology MR O'Donnell, MS Tallman, CN Abboud, JK Altman, FR Appelbaum, ... Journal of the National Comprehensive Cancer Network 15 (7), 926-957, 2017 | 421 | 2017 |
| Diffuse large B‐cell lymphoma with primary treatment failure: ultra‐high risk features and benchmarking for experimental therapies LJ Costa, K Maddocks, N Epperla, NM Reddy, R Karmali, E Umyarova, ... American journal of hematology 92 (2), 161-170, 2017 | 83 | 2017 |
| Adipocyte-lineage cells support growth and dissemination of multiple myeloma in bone TN Trotter, JT Gibson, TL Sherpa, PS Gowda, D Peker, Y Yang The American journal of pathology 186 (11), 3054-3063, 2016 | 76 | 2016 |
| Myeloma cell-derived Runx2 promotes myeloma progression in bone YY Trotter TN, Li M, Pan Q, Peker D, Rowan PD, Li J, Zhan F, Suva LJ, Javed A Blood, 2015 | 54* | 2015 |
| A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institution D Peker, E Padron, JM Bennett, X Zhang, P Horna, PK Epling-Burnette, ... Acta haematologica 133 (2), 249-256, 2015 | 51 | 2015 |
| The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms P Li, S Brown, M Williams, T White, W Xie, W Cui, D Peker, L Lei, ... Blood, The Journal of the American Society of Hematology 140 (7), 716-755, 2022 | 43 | 2022 |
| AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome P Li, T White, W Xie, W Cui, D Peker, G Zeng, HY Wang, J Vagher, ... Leukemia 36 (3), 664-674, 2022 | 35 | 2022 |
| Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemia DI Ullman, D Dorn, JA Jones, D Fasciano, Z Ping, C Kanakis, RG Koenig, ... Histopathology 75 (2), 185-192, 2019 | 27 | 2019 |
| Azathioprine induced Epstein Barr virus-positive mucocutaneous ulcer arising in perianal fistula and abscess associated with Crohn's disease R Matnani, D Peker Journal of Crohn's and Colitis 8 (12), 1747-1748, 2014 | 27 | 2014 |
| Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells J Li, Q Pan, PD Rowan, TN Trotter, D Peker, KM Regal, A Javed, LJ Suva, ... Oncotarget 7 (10), 11299, 2016 | 24 | 2016 |
| Grading and prognostication of neuroendocrine tumors of the pancreas: a comparison study of Ki67 and PHH3 J Tracht, K Zhang, D Peker Journal of Histochemistry & Cytochemistry 65 (7), 399-405, 2017 | 21 | 2017 |
| Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single‐center experience and literature review R Paluri, L Nabell, S Borak, D Peker Hematological Oncology 33 (4), 206-211, 2015 | 21 | 2015 |
| Lymphangioma of the ovary: a case report and review of the literature EU Akyildiz, D Peker, S Ilvan, Z Calay, I Cetinaslan, N Oruc JOURNAL-BALKAN UNION OF ONCOLOGY 11 (1), 91, 2006 | 19 | 2006 |
| Osteocyte apoptosis attracts myeloma cells to bone and supports progression through regulation of the bone marrow microenvironment TN Trotter, M Fok, JT Gibson, D Peker, A Javed, Y Yang Blood 128 (22), 484, 2016 | 16 | 2016 |
| Malignant transformation in von-meyenburg complexes: Histologic and immunohistochemical clues with illustrative cases V Parekh, D Peker Applied Immunohistochemistry & Molecular Morphology 23 (9), 607-614, 2015 | 15 | 2015 |
| Plasmablastic microlymphoma arising in human herpesvirus‐8‐associated multicentric Castleman disease in a human immunodeficiency virus‐seronegative patient with clinical … G Koenig, TM Stevens, D Peker Histopathology 67 (6), 930-932, 2015 | 14 | 2015 |
| Burkitt Lymphoma Arising From Lymphoplasmacytic Lymphoma Following Acquisition of MYC Translocation and Loss of the ETV6 Tumor Suppressor Gene D Peker, B Quigley, D Qin, P Papenhausen, L Zhang Archives of pathology & laboratory medicine 137 (1), 130-133, 2013 | 13 | 2013 |
| Complete remission in 4 patients with human herpesvirus 8-associated multicentric castleman disease using rituximab and liposomal Doxorubicin, a novel chemotherapy combination. CM Peker D, Martinez AE, Schwartz MA Clinical advances in hematology and oncology 10 (3), 204-206, 2012 | 13 | 2012 |
| Extramedullary involvement by chronic myelogeneous leukemia in five patients with unusual clinicopathologic features: a review of the effectiveness of tyrosine kinase inhibitors A Soni, R Paluri, T Deal, D Peker Journal of clinical medicine research 8 (6), 480, 2016 | 12 | 2016 |
